{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:43:01Z","timestamp":1793727781953,"version":"4.6.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:00:00Z","timestamp":1783123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-75208-0","type":"journal-article","created":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T15:34:32Z","timestamp":1783179272000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Reprogramming macrophage immunometabolism via glutamine antagonism potentiates colorectal cancer therapy in mice"],"prefix":"10.1038","volume":"17","author":[{"given":"Renming","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xintong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuang","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongrui","family":"Hai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5122-2226","authenticated-orcid":false,"given":"Qiu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7180-7176","authenticated-orcid":false,"given":"Gaofei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,4]]},"reference":[{"key":"75208_CR1","doi-asserted-by":"crossref","unstructured":"Ouladan, S., Orouji, E. Chimeric antigen receptor-T cells in colorectal cancer: pioneering new avenues in solid tumor immunotherapy. J. Clin. Oncol. 43, Jco2402081 (2025).","DOI":"10.1200\/JCO-24-02081"},{"key":"75208_CR2","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41392-024-01953-7","volume":"9","author":"Q Li","year":"2024","unstructured":"Li, Q. et al. Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy. Signal Transduct. Target Ther. 9, 266 (2024).","journal-title":"Signal Transduct. Target Ther."},{"key":"75208_CR3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13045-024-01578-x","volume":"17","author":"X Chong","year":"2024","unstructured":"Chong, X. et al. Recent developments in immunotherapy for gastrointestinal tract cancers. J. Hematol. Oncol. 17, 65 (2024).","journal-title":"J. Hematol. Oncol."},{"key":"75208_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01801-2","volume":"22","author":"Y Wu","year":"2023","unstructured":"Wu, Y., Song, Y., Wang, R. & Wang, T. Molecular mechanisms of tumor resistance to radiotherapy. Mol. Cancer 22, 96 (2023).","journal-title":"Mol. Cancer"},{"key":"75208_CR5","doi-asserted-by":"crossref","unstructured":"Haque, P. S., Kapur, N., Barrett, T. A. & Theiss, A. L. Mitochondrial function and gastrointestinal diseases. Nat, Rev. Gastroenterol. Hepatol. 21, 537\u2013555 (2024).","DOI":"10.1038\/s41575-024-00931-2"},{"key":"75208_CR6","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1146\/annurev-pathmechdis-031521-041113","volume":"18","author":"JC Sedlak","year":"2023","unstructured":"Sedlak, J. C., Yilmaz, \u00d6H. & Roper, J. Metabolism and colorectal cancer. Annu. Rev. Pathol. 18, 467\u2013492 (2023).","journal-title":"Annu. Rev. Pathol."},{"key":"75208_CR7","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13046-024-02994-0","volume":"43","author":"B Wang","year":"2024","unstructured":"Wang, B., Pei, J., Xu, S., Liu, J. & Yu, J. A glutamine tug-of-war between cancer and immune cells: recent advances in unraveling the ongoing battle. J. Exp. Clin. Cancer Res. 43, 74 (2024).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"75208_CR8","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s43018-020-0035-5","volume":"1","author":"TQ Tran","year":"2020","unstructured":"Tran, T. Q. et al. \u03b1-Ketoglutarate attenuates Wnt signaling and drives differentiation in colorectal cancer. Nat. Cancer 1, 345\u2013358 (2020).","journal-title":"Nat. Cancer"},{"key":"75208_CR9","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.semcancer.2022.03.023","volume":"86","author":"C Zhang","year":"2022","unstructured":"Zhang, C., Quinones, A. & Le, A. Metabolic reservoir cycles in cancer. Semin Cancer Biol. 86, 180\u2013188 (2022).","journal-title":"Semin Cancer Biol."},{"key":"75208_CR10","doi-asserted-by":"crossref","unstructured":"Guo C. et al. SLC38A2 and glutamine signalling in cDC1s dictate anti-tumor immunity. Nature 620, 200\u2013208 (2023).","DOI":"10.1038\/s41586-023-06299-8"},{"key":"75208_CR11","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1126\/science.aav2588","volume":"366","author":"RD Leone","year":"2019","unstructured":"Leone, R. D. et al. Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion. Science 366, 1013\u20131021 (2019).","journal-title":"Science"},{"key":"75208_CR12","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1002\/cac2.12459","volume":"43","author":"X Hu","year":"2023","unstructured":"Hu, X. et al. Glutamine metabolic microenvironment drives M2 macrophage polarization to mediate trastuzumab resistance in HER2-positive gastric cancer. Cancer Commun. 43, 909\u2013937 (2023).","journal-title":"Cancer Commun."},{"key":"75208_CR13","first-page":"1033","volume":"63","author":"R Catane","year":"1979","unstructured":"Catane, R., Von Hoff, D. D., Glaubiger, D. L. & Muggia, F. M. Azaserine, DON, and azotomycin: three diazo analogs of L-glutamine with clinical antitumor activity. Cancer Treat. Rep. 63, 1033\u20131038 (1979).","journal-title":"Cancer Treat. Rep."},{"key":"75208_CR14","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.trecan.2021.04.003","volume":"7","author":"WH Yang","year":"2021","unstructured":"Yang, W. H., Qiu, Y., Stamatatos, O., Janowitz, T. & Lukey, M. J. Enhancing the efficacy of glutamine metabolism inhibitors in cancer therapy. Trends Cancer 7, 790\u2013804 (2021).","journal-title":"Trends Cancer"},{"key":"75208_CR15","doi-asserted-by":"crossref","unstructured":"Recouvreux M. V. et al. Glutamine mimicry suppresses tumor progression through asparagine metabolism in pancreatic ductal adenocarcinoma. Nat. Cancer 5, 100\u201310(2023).","DOI":"10.1038\/s43018-023-00649-1"},{"key":"75208_CR16","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abq5925","volume":"8","author":"R Rais","year":"2022","unstructured":"Rais, R. et al. Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrug. Sci. Adv. 8, eabq5925 (2022).","journal-title":"Sci. Adv."},{"key":"75208_CR17","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1158\/1535-7163.MCT-17-1148","volume":"17","author":"KM Lemberg","year":"2018","unstructured":"Lemberg, K. M., Vornov, J. J., Rais, R. & Slusher, B. S. We\u2019re Not \u201cDON\u201d yet: optimal dosing and prodrug delivery of 6-Diazo-5-oxo-L-norleucine. Mol. Cancer Ther. 17, 1824\u20131832 (2018).","journal-title":"Mol. Cancer Ther."},{"key":"75208_CR18","doi-asserted-by":"crossref","unstructured":"Zheng, J. et al. Tumor-targeted glutamine metabolism blocker synergizes with TiO(2)-Au Janus nanoparticles for enhanced sono-metabolic antitumor therapy. Adv. Mater. 37, e2418800 (2025).","DOI":"10.1002\/adma.202418800"},{"key":"75208_CR19","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/s41590-023-01430-3","volume":"24","author":"PS Liu","year":"2023","unstructured":"Liu, P. S. et al. CD40 signal rewires fatty acid and glutamine metabolism for stimulating macrophage anti-tumorigenic functions. Nat. Immunol. 24, 452\u2013462 (2023).","journal-title":"Nat. Immunol."},{"key":"75208_CR20","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.cmet.2023.04.013","volume":"35","author":"Z Wang","year":"2023","unstructured":"Wang, Z. et al. Extracellular vesicles in fatty liver promote a metastatic tumor microenvironment. Cell Metab. 35, 1209\u20131226.e1213 (2023).","journal-title":"Cell Metab."},{"key":"75208_CR21","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.ccell.2022.08.012","volume":"40","author":"Q Shi","year":"2022","unstructured":"Shi, Q. et al. Increased glucose metabolism in TAMs fuels O-GlcNAcylation of lysosomal Cathepsin B to promote cancer metastasis and chemoresistance. Cancer Cell 40, 1207\u20131222.e1210 (2022).","journal-title":"Cancer Cell"},{"key":"75208_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-57603-1","volume":"16","author":"Z Wen","year":"2025","unstructured":"Wen, Z. et al. Interleukin-16 enhances anti-tumor immune responses by establishing a Th1 cell-macrophage crosstalk through reprogramming glutamine metabolism in mice. Nat. Commun. 16, 2362 (2025).","journal-title":"Nat. Commun."},{"key":"75208_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jconrel.2024.12.073","volume":"379","author":"S Chen","year":"2025","unstructured":"Chen, S. et al. Folate-targeted nanoparticles for glutamine metabolism inhibition enhance anti-tumor immunity and suppress tumor growth in ovarian cancer. J. Control Release 379, 89\u2013104 (2025).","journal-title":"J. Control Release"},{"key":"75208_CR24","doi-asserted-by":"crossref","unstructured":"Wang, X. et al. Platinum-based TREM2 inhibitor suppresses tumor via remodeling immunosuppressive microenvironment. Angew Chem. Int. Ed Engl. 62, 13337 (2022).","DOI":"10.1002\/anie.202213337"},{"key":"75208_CR25","doi-asserted-by":"publisher","first-page":"277","DOI":"10.7150\/thno.101001","volume":"15","author":"A Deng","year":"2025","unstructured":"Deng, A. et al. A STING agonist prodrug reprograms tumor-associated macrophage to boost colorectal cancer immunotherapy. Theranostics 15, 277\u2013299 (2025).","journal-title":"Theranostics"},{"key":"75208_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70120","volume":"6","author":"MA Kumar","year":"2025","unstructured":"Kumar, M. A. et al. Glutamine metabolism: molecular regulation, biological functions, and diseases. MedComm 6, e70120 (2025).","journal-title":"MedComm"},{"key":"75208_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115306","volume":"252","author":"Y Chen","year":"2023","unstructured":"Chen, Y. et al. Targeting glutaminase 1 (GLS1) by small molecules for anticancer therapeutics. Eur. J. Med. Chem. 252, 115306 (2023).","journal-title":"Eur. J. Med. Chem."},{"key":"75208_CR28","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/ni.3796","volume":"18","author":"PS Liu","year":"2017","unstructured":"Liu, P. S. et al. alpha-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming. Nat. Immunol. 18, 985\u2013994 (2017).","journal-title":"Nat. Immunol."},{"key":"75208_CR29","doi-asserted-by":"crossref","unstructured":"Wang, J. et al. Targeted delivery of \u03b1-ketoglutarate to macrophages in bone: a novel therapeutic strategy for improving fracture healing in type 2 diabetes. Adv. Sci. 12, e2415667 (2025).","DOI":"10.1002\/advs.202415667"},{"key":"75208_CR30","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.trecan.2019.10.007","volume":"5","author":"K Mehla","year":"2019","unstructured":"Mehla, K. & Singh, P. K. Metabolic regulation of macrophage polarization in cancer. Trends Cancer 5, 822\u2013834 (2019).","journal-title":"Trends Cancer"},{"key":"75208_CR31","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang, D. et al. Metabolic regulation of gene expression by histone lactylation. Nature 574, 575\u2013580 (2019).","journal-title":"Nature"},{"key":"75208_CR32","doi-asserted-by":"crossref","unstructured":"Chen, Y. et al. Metabolic regulation of homologous recombination repair by MRE11 lactylation. Cell 187, 297\u2013311 (2023).","DOI":"10.1016\/j.cell.2023.11.022"},{"key":"75208_CR33","doi-asserted-by":"crossref","unstructured":"Chen, H. et al. NBS1 lactylation is required for efficient DNA repair and chemotherapy resistance. Nature 631, 663\u2013669 (2024).","DOI":"10.1038\/s41586-024-07620-9"},{"key":"75208_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09982-5","volume":"10","author":"HS Kaya-Okur","year":"2019","unstructured":"Kaya-Okur, H. S. et al. CUT&Tag for efficient epigenomic profiling of small samples and single cells. Nat. Commun. 10, 1930 (2019).","journal-title":"Nat. Commun."},{"key":"75208_CR35","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.1038\/s41596-020-0373-x","volume":"15","author":"HS Kaya-Okur","year":"2020","unstructured":"Kaya-Okur, H. S., Janssens, D. H., Henikoff, J. G., Ahmad, K. & Henikoff, S. Efficient low-cost chromatin profiling with CUT&Tag. Nat. Protoc. 15, 3264\u20133283 (2020).","journal-title":"Nat. Protoc."},{"key":"75208_CR36","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1126\/science.1219855","volume":"337","author":"RJ Youle","year":"2012","unstructured":"Youle, R. J. & van der Bliek, A. M. Mitochondrial fission, fusion, and stress. Science 337, 1062\u20131065 (2012).","journal-title":"Science"},{"key":"75208_CR37","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41556-022-00843-w","volume":"24","author":"P Romani","year":"2022","unstructured":"Romani, P. et al. Mitochondrial fission links ECM mechanotransduction to metabolic redox homeostasis and metastatic chemotherapy resistance. Nat. Cell Biol. 24, 168\u2013180 (2022).","journal-title":"Nat. Cell Biol."},{"key":"75208_CR38","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s43018-022-00354-5","volume":"3","author":"J Li","year":"2022","unstructured":"Li, J. et al. Macrophage mitochondrial fission improves cancer cell phagocytosis induced by therapeutic antibodies and is impaired by glutamine competition. Nat. Cancer 3, 453\u2013470 (2022).","journal-title":"Nat. Cancer"},{"key":"75208_CR39","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.cell.2017.08.041","volume":"171","author":"Y Wang","year":"2017","unstructured":"Wang, Y. et al. Mitochondrial fission promotes the continued clearance of apoptotic cells by macrophages. Cell 171, 331\u2013345.e322 (2017).","journal-title":"Cell"},{"key":"75208_CR40","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.tips.2023.01.003","volume":"44","author":"AE Shin","year":"2023","unstructured":"Shin, A. E., Giancotti, F. G. & Rustgi, A. K. Metastatic colorectal cancer: mechanisms and emerging therapeutics. Trends Pharm. Sci. 44, 222\u2013236 (2023).","journal-title":"Trends Pharm. Sci."},{"key":"75208_CR41","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.annonc.2022.10.003","volume":"34","author":"A Cervantes","year":"2023","unstructured":"Cervantes, A. et al. Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann. Oncol. 34, 10\u201332 (2023).","journal-title":"Ann. Oncol."},{"key":"75208_CR42","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s12029-023-00927-2","volume":"54","author":"J El Hajj","year":"2023","unstructured":"El Hajj, J., Reddy, S., Verma, N., Huang, E. H. & Kazmi, S. M. Immune checkpoint inhibitors in pMMR\/MSS colorectal cancer. J. Gastrointest. Cancer 54, 1017\u20131030 (2023).","journal-title":"J. Gastrointest. Cancer"},{"key":"75208_CR43","doi-asserted-by":"publisher","first-page":"4802","DOI":"10.7150\/thno.73746","volume":"12","author":"K Zhang","year":"2022","unstructured":"Zhang, K. et al. N6-methyladenosine-mediated LDHA induction potentiates chemoresistance of colorectal cancer cells through metabolic reprogramming. Theranostics 12, 4802\u20134817 (2022).","journal-title":"Theranostics"},{"key":"75208_CR44","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.7150\/thno.30056","volume":"9","author":"F Deng","year":"2019","unstructured":"Deng, F. et al. Tumor-secreted dickkopf2 accelerates aerobic glycolysis and promotes angiogenesis in colorectal cancer. Theranostics 9, 1001\u20131014 (2019).","journal-title":"Theranostics"},{"key":"75208_CR45","doi-asserted-by":"crossref","unstructured":"Fusco, M. J. et al. FDA approval summary: fruquintinib for the treatment of refractory metastatic colorectal cancer. Clin. Cancer Res. 30, 3100\u20133104 (2024).","DOI":"10.1158\/1078-0432.CCR-24-0281"},{"key":"75208_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-59588-3","volume":"16","author":"X Qu","year":"2025","unstructured":"Qu, X. et al. Ligand-activated EGFR\/MAPK signaling but not PI3K, are key resistance mechanisms to EGFR-therapy in colorectal cancer. Nat. Commun. 16, 4332 (2025).","journal-title":"Nat. Commun."},{"key":"75208_CR47","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1158\/1078-0432.CCR-22-1366","volume":"29","author":"SA Patel","year":"2023","unstructured":"Patel, S. A. et al. Molecular mechanisms and future implications of VEGF\/VEGFR in cancer therapy. Clin. Cancer Res. 29, 30\u201339 (2023).","journal-title":"Clin. Cancer Res."},{"key":"75208_CR48","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41392-022-01212-7","volume":"8","author":"K Wei","year":"2023","unstructured":"Wei, K. et al. Chemo-drugs in cell microparticles reset antitumor activity of macrophages by activating lysosomal P450 and nuclear hnRNPA2B1. Signal Transduct. Target Ther. 8, 22 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"75208_CR49","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adx5495","volume":"11","author":"J Yang","year":"2025","unstructured":"Yang, J. et al. STK11 coordinates IL-4 signaling with metabolic reprogramming to control M2 macrophage polarization and antitumor immunity. Sci. Adv. 11, eadx5495 (2025).","journal-title":"Sci. Adv."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75208-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75208-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75208-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T23:14:57Z","timestamp":1786576497000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75208-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,4]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["75208"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-75208-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,4]]},"assertion":[{"value":"3 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"8318"}}